Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?

Immunologic Research

Volumn 64, Issue 2, 2016, Pages 636-639

  Zidi, Inès ^a   Kharrat, Najla ^b   Sebai, Refaat ^c   Zidi, Nour ^c   Yahia, Hamza Ben ^a   Bouaziz, Aicha ^d   Rifi, Hela ^c   Mezlini, Amel ^c   Rizzo, Roberta ^e  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^c SALAH AZAIEZ INSTITUTE   (Tunisia)

^d University of Tunis El Manar   (Tunisia)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

Breast cancer; Breastfeeding; Pregnancy; sHLA G

Indexed keywords

HLA G ANTIGEN; SOLUBLE HLA G ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; BREAST CANCER; BREAST FEEDING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; BREAST TUMOR; IMMUNOLOGY; PATHOLOGY;

ADULT; BREAST FEEDING; BREAST NEOPLASMS; FEMALE; HLA-G ANTIGENS; HUMANS; PREGNANCY;

EID: 84961155553     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8764-8     Document Type: Letter

References (20)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
2. Economopoulou P, Dimitriadis G, Psyrri A. Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev. 2015;41(1):1–8.
3. da Silva GB, Silva TG, Duarte RA, Neto NL, Carrara HH, Donadi EA, et al. Expression of the classical and nonclassical HLA molecules in breast cancer. Int J Breast Cancer. 2013;2013:250435.
4. Djurisic S, Hviid TV. HLA Class Ib molecules and immune cells in pregnancy and preeclampsia. Front Immunol. 2014;5:652.
5. Lynge Nilsson L, Djurisic S, Hviid TV. Controlling the immunological crosstalk during conception and pregnancy: HLA-G in reproduction. Front Immunol. 2014;5:198.
6. Ellis SA, Palmer MS, McMichael AJ. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol Res. 1990;144(2):731–5.
7. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol. 2003;59(2):219–34.
8. Bıyık I. Maternal serum soluble HLA-G in complicated pregnancies. J Matern Fetal Neonatal Med. 2014;27(4):381–4.
9. Wang X, Jiang W, Zhang D. Association of 14-bp insertion/deletion polymorphism of HLA-G gene with unexplained recurrent spontaneous abortion: a meta-analysis. Tissue Antigens. 2013;81(2):108–15.
10. Dahl M, Djurisic S, Hviid TV. The many faces of human leukocyte antigen-G: relevance to the fate of pregnancy. J Immunol Res. 2014;2014:591489.
11. Loumagne L, Baudhuin J, Favier B, Montespan F, Carosella ED, Rouas-Freiss N. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance. Int J Cancer. 2014;135(9):2107–17.
12. Dias FC, Castelli EC, Collares CV, Moreau P, Donadi EA. The role of HLA-G molecule and HLA-G gene polymorphisms in tumors, viral Hepatitis, and parasitic diseases. Front Immunol. 2015;6:9.
13. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens. 2008;72(4):335–41.
14. Rudstein-Svetlicky N, Loewenthal R, Horejsi V, Gazit E. HLA-G levels in serum and plasma. Tissue Antigens. 2006;67(2):111–6.
15. Rizzo R, Andersen AS, Lassen MR, Sørensen HC, Bergholt T, Larsen MH, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol. 2009;62(5):320–38.
16. Rizzo R, Stignani M, Amoudruz P, Nilsson C, Melchiorri L, Baricordi O, et al. Allergic women have reduced sHLA-G plasma levels at delivery. Am J Reprod Immunol. 2009;61(5):368–76.
17. Kleinberg L, Flørenes VA, Skrede M, Dong HP, Nielsen S, McMaster MT, et al. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch. 2006;449(1):31–9.
18. Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, Zhang X, et al. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer. Hum Immunol. 2010;71(9):892–8.
19. He X, Dong DD, Yie SM, Yang H, Cao M, Ye SR, et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol. 2010;17(5):1459–69.
20. de Kruijf EM, Sajet A, van Nes JG, Natanov R, Putter H, Smit VT, et al. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol. 2010;185(12):7452–9.